Form 8-K - Current report:
SEC Accession No. 0001193125-22-200476
Filing Date
2022-07-25
Accepted
2022-07-25 08:00:40
Documents
12
Period of Report
2022-07-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d387303d8k.htm   iXBRL 8-K 27134
  Complete submission text file 0001193125-22-200476.txt   150568

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA txmd-20220724.xsd EX-101.SCH 2878
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE txmd-20220724_lab.xml EX-101.LAB 17995
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE txmd-20220724_pre.xml EX-101.PRE 11276
6 EXTRACTED XBRL INSTANCE DOCUMENT d387303d8k_htm.xml XML 3347
Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431
Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

EIN.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-00100 | Film No.: 221101264
SIC: 2834 Pharmaceutical Preparations